ONEighty C Technologies Corporation

WAVEPulse™ Sterilization and Verification System is a patent-pending high-performance platform sterilizing temp-sensitive medical devices such as endoscopes.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Concord, MA, USA
  • Currency USD
  • Founded April 2013
  • Employees 6
  • Incorporation Type C-corp
  • Website oneightyc.com

Company Summary

WAVEPulse overcomes infection risk from improperly cleaned temp-sensitive endoscopes. Unique combination of energies, temp control and non-toxic solvents.

Patented (April 2019) verification arms hospitals with unavailable information of medically-critical pathogens that can remain after reprocessing.

High-margin, consumable proprietary solvents, sterile wraps and single-use verification arrays are a key part of system.

Team

  • Eric Walters
    CEO, Co-Founder and Director

    CPA. Raised more than $100 million in capital. Formerly EVP/CFO and member of senior management team of $1M medical device start-up company (PolyMedica) that grew to $350M in profitable revenues, late sold for $1.5B in cash when its revenues exceeded $675M.

  • Michael Fritz
    Board of Directors

    More than 20 years Big Four consulting and line management experience dramatically improving operational, financial and service outcomes. Core capabilities include excellent project management skills, team building, and a passion for moving organizations forward to achieve their true potential.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free